Tuğba KAMAN

Dr. Tuğba KAMAN

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2019 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
TKTuğba KAMAN
Tuğba KAMAN
ÖKÖmer Faruk Karasakal
Ömer Faruk Karasakal
EOEbru Özkan Oktay
Ebru Özkan Oktay
KUKorkut Ulucan
Korkut Ulucan
ÜUÜsküdar University
Üsküdar University
The apoptotic protease activating factor 1 (APAF1) gene encodes a cytoplasmic protein that initiates apoptosis and is a crucial factor in the mitochondria-dependent death pathway. APAF1 is implicated in many pathways such as apoptosis, neurodegenerative diseases, and cancer. The purpose of this study was to predict deleterious/damaging SNPs in the APAF1 gene via in silico analysis. To this end, APAF1 missense SNPs were obtained from the NCBI dbSNP database. In silico analysis of the missense SNPs was carried out by using publicly available online software tools. The stabilization and three-dimensional modeling of mutant proteins were also determined by using the I-Mutant 2.0 and Project HOPE webservers, respectively. In total, 772 missense SNPs were found in the APAF1 gene from the NCBI dbSNP database, 18 SNPs of which were demonstrated to be deleterious or damaging. Of those, 13 SNPs had a decreasing effect on protein stability, while the other 5 SNPs had an increasing effect. Based on the modeling results, some dissimilarities of mutant type amino acids from wild-type amino acids such as size, charge, and hydrophobicity were revealed. The SNPs predicted to be deleterious in this study might be used in the selection of target SNPs for genotyping in disease association studies. Therefore, we could suggest that the present study could pave the way for future experimental studies.

22 November 2021 in International Journal of Environmental Analytical Chemistry
Verified
Journal Article
Closed access
MKMirac Kamislioglu
Mirac Kamislioglu
CECanel Eke
Canel Eke
TKTuğba KAMAN
Tuğba KAMAN
IBIsmail Boztosun
Ismail Boztosun
In this study, natural and artificial radionuclide concentrations were determined and radiological dose values of nine different medicinal plants {Sweet marjoram (Origanum majorana), Rosemary (Rosmarinus officinalis) Lavender (Lavandula x intermedia), Thyme (Thymus vulgaris), Sage (Salvia officinalis), Peppermint (Mentha piperita), Holy basil (Ocimum Sanctum), Bush basil (Ocimum minimum) and Lemon balm (Melissa officinalis)} used in Balikesir province from Turkey were evaluated. Gamma-ray spectrometry was used to determine the natural and artificial radionuclide concentrations of these medicinal plants. To evaluate radiological dose values, absorbed gamma dose rate (D), radium equivalent activity (Raeq) annual gonadal dose equivalent (AGDE), exposure dose (ER), annual effective dose (AED), excess lifetime cancer risk (ELCR), internal hazard index (Hin), external hazard index (Hex) and gamma representative level (GRL) were determined. Mean values of 226Ra and 232Th activity concentrations are lower than the world average values, whereas mean values of 40K activity concentrations are higher than the world average values for present medicinal plants. Lavandula x intermedia has the highest 137Cs concentration, whilst Thymus vulgaris L. has the lowest 137Cs activity concentration. D, Raeq, AGDE, ER, AED and ECLR values are the highest for Lavandula x intermedia, whilst they are the smallest for Rosmarinus officinalis L. among the studied medicinal plants. Average values of Hin and Hex are lower than the permissible value of 1, whilst the average value of GRL is higher than permissible limit value of 1.

9 June 2023 in Biochemical Genetics
Verified
Journal Article
Open access
PDF file
EOEbru Özkan Oktay
Ebru Özkan Oktay
TKTuğba KAMAN
Tuğba KAMAN
ÖKÖmer Faruk Karasakal
Ömer Faruk Karasakal
VAVildan Enisoğlu Atalay
Vildan Enisoğlu Atalay
Neuropilin-1 (NRP1) which is a main transmembrane cell surface receptor acts as a host cell mediator resulting in increasing the SARS-Cov-2 infectivity and also plays a role in neuronal development, angiogenesis and axonal outgrowth. The goal of this study is to estimate the impact of single nucleotide polymorphisms (SNPs) in the NRP1 gene on the function, structure and stabilization of protein as well as on the miRNA-mRNA binding regions using bioinformatical tools. It is also aimed to investigate the changes caused by SNPs in NRP1 on interactions with drug molecule and spike protein. The missense type of SNPs was analyzed using SIFT, PolyPhen-2, SNAP2, PROVEAN, Mutation Assessor, SNPs&GO, PhD-SNP, I-Mutant 3.0, MUpro, STRING, Project HOPE, ConSurf, and PolymiRTS. Docking analyses were conducted by AutoDock Vina program. As a result, a total of 733 missense SNPs were determined within the NRP1 gene and nine SNPs were specified as damaging to the protein. The modelling results showed that wild and mutant type amino acids had some different properties such as size, charge, and hydrophobicity. Additionally, their three-dimensional structures of protein were utilized for confirmation of these differences. After evaluating the results, nine polymorphisms rs141633354, rs142121081, rs145954532, rs200028992, rs200660300, rs369312020, rs370117610, rs370551432, rs370641686 were determined to be damaging on the structure and function of NRP1 protein and located in conserved regions. The results of molecular docking showed that the binding affinity values are nearly the same for wild-type and mutant structures support that the mutations carried out are not in the focus of the binding site, therefore the ligand does not affect the binding energy. It is expected that the results will be useful for future studies.

30 August 2021 in TURKISH JOURNAL OF BIOLOGY
Verified
Journal Article
Open access
EOEbru Özkan Oktay
Ebru Özkan Oktay
STSalih Tuncay
Salih Tuncay
TKTuğba KAMAN
Tuğba KAMAN
ÖKÖmer Faruk Karasakal
Ömer Faruk Karasakal
ÖÖÖznur Özge Özcan
Öznur Özge Özcan
ÜUÜsküdar University
Üsküdar University
Various recently reported mutant variants, candidate and urgently approved current vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many current situations with severe neurological damage and symptoms as well as respiratory tract disorders have begun to be reported. In particular, drug, vaccine, and neutralizing monoclonal antibodies (mAbs) have been developed and are currently being evaluated in clinical trials. Here, we review lessons learned from the use of novel mutant variants of the COVID-19 virus, immunization, new drug solutions, and antibody therapies for infections. Next, we focus on the B 1.1.7, B 1.351, P.1, and B.1.617 lineages or variants of concern that have been reported worldwide, the new manifestations of neurological manifestations, the current therapeutic drug targets for its treatment, vaccine candidates and their efficacy, implantation of convalescent plasma, and neutralization of mAbs. We review specific clinical questions, including many emerging neurological effects and respiratory tract injuries, as well as new potential biomarkers, new studies in addition to known therapeutics, and chronic diseases of vaccines that have received immediate approval. To answer these questions, further understanding of the burden kinetics of COVID-19 and its correlation with neurological clinical outcomes, endogenous antibody responses to vaccines, pharmacokinetics of neutralizing mAbs, and action against emerging viral mutant variants is needed.

25 August 2019 in SDÜ Fen Bilimleri Enstitüsü Dergisi
Verified
Journal Article
Open access
EOEbru Özkan Oktay
Ebru Özkan Oktay
TKTuğba KAMAN
Tuğba KAMAN
ÖKÖmer Faruk Karasakal
Ömer Faruk Karasakal
KUKorkut Ulucan
Korkut Ulucan
ÜUÜsküdar University
Üsküdar University
NTNevzat Tarhan
Nevzat Tarhan
Alzheimer hastalığı (AH), β-amiloid (Aβ) senil plakların ve nörofibriler yumakların patolojik birikimi ile karakterize olan ilerleyici bir nörodejeneratif hastalıktır. γ-sekretaz, AH nedeni olan amiloid β peptidi (Aβ) üretmektedir. γ-sekretaz makromoleküler bir komplekstir ve APH1A geninin kodladığı protein bu komplekste yer almaktadır. Bu çalışmada, APH1A genindeki yanlış anlamlı (missense) tek nükleotid polimorfizmlerinin (SNP) proteinin yapısı ve stabilizasyonu üzerindeki olası zararlı etkilerinin in silico yöntemler kullanılarak belirlenmesi amaçlanmıştır. Zararlı SNP’lerin tahmin edilmesi için PolyPhen-2 ve SIFT yazılım araçları, protein stabilizasyonu değişimlerinin tespit edilmesi için I-Mutant 2.0 yazılımı, yabanıl ve mutant tip proteinlerin üç boyutlu modellemeleri için Project HOPE yazılım aracı kullanılmıştır. Sonuçlar, APH1A geninde yer alan toplam 3567 SNP’nin 257 tanesinin yanlış anlamlı SNP olduğunu göstermiştir. 257 SNP’nin in silico analizlerine göre, rs11548266, rs74126634, rs145324799, rs199961673, rs370361277, rs370719475 ve rs376071112 polimorfizmlerinin zararlı etkilerinin olabileceği belirlenmiştir. Çalışmamızda gerçekleştirdiğimiz in silico analizler, Alzheimer hastalığı ile ilgili APH1A geninde yer alan 3567 SNP’nin tamamının genotiplenmesi yerine proteinin yapısı ve stabilizasyonuna zararlı etkisi olabilecek SNP’lerin genotiplenmesine ilişkin veri sağlamaktadır. Dolayısıyla, zararlı olduğu tespit edilen SNP’ler genotipleme çalışmalarının en önemli basamağı olan SNP seçiminde ve deney tasarımında kullanılabilecektir. Bu nedenle, elde ettiğimiz sonuçların Alzheimer hastalığı ile ilgili gelecekte yapılacak olan hem deneysel hem de in silico çalışmalara katkı sağlayacağı düşünülmektedir.

28 March 2024 in Turkish Journal of Science and Technology
Verified
Journal Article
Open access
PDF file
ARAzadeh Rezaeirad
Azadeh Rezaeirad
ÖKÖmer Faruk Karasakal
Ömer Faruk Karasakal
TKTuğba KAMAN
Tuğba KAMAN
MKMesut Karahan
Mesut Karahan
Autism spectrum disorder (ASD) is defined as a pervasive and multifactorial neurodevelopmental disorder (ND). It is characterized by repetitive behavioral patterns as well as symptoms of social interaction and communication disorder. The cadherin (CDH) superfamily is a large group of synaptic cell adhesion molecules and has been widely related with ND, including autism. The aim of this study is to evaluate the potentially deleterious missense single nucleotide polymorphisms (SNPs) in CDH8 and CDH10 genes, which are related with ASD and cause amino acid changes, using internet-based software tools. To identify potentially harmful missense SNPs; all SNPs were screened using SIFT, PolyPhen-2, PROVEAN, SNPs&GO, Meta-SNP, and SNAP2 software tools, and common deleterious ones were filtered out. Its effect on protein stabilization was investigated with I-Mutant 3.0 and MUpro tools. Three-dimensional models of these common damaging amino acid changes were evaluated with the HOPE software. As a result of in silico analysis of 577 missense SNPs in the CDH8 gene; The rs145143780 (Y572C) polymorphism common damaging ‎SNP has been detected by all software tools.‎ According to the results of the in silico analysis of 526 missense SNPs found in the CDH10 gene; The rs13174039 (V459G), rs147882578 (N485K), rs201423740 (Y306C), rs201956238 (F317L) and rs373340564 (R128C) common damaging SNPs have been identified in all polymorphisms by all software tools. As a result of this study, it is thought that the data obtained will make important contributions to future relevant experimental studies.